Journal of Veterinary Clinics (한국임상수의학회지)

The Korean Society of Veterinary Clinics (한국임상수의학회)
권호 표지
DOI QR코드

DOI QR Code

Application of a Synbio-Glucan Functional Spray for Canine Atopic Dermatitis

  • Yoon-Hwan Kim (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Yunho Jeong (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Ju-Hyun An (Department of Veterinary Emergency and Critical Care Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Jin-Ok Ahn (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Jin-Young Chung (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University)
  • Received : 2022.12.06
  • Accepted : 2023.01.27
  • Published : 2023.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Atopic dermatitis (AD) is a common skin disease in animals and several therapeutic trials with various drugs have been conducted for more effective management of AD. However, these trials have not been able to properly address all the aspects of AD management because of the lack of good efficacy or due to significant side effects of the drugs being tested. Synbio-glucan functional spray is a functional skin spray using Synbio-glucan composed of β-glucan and probiotics. We designed a functional spray composed of Synbio-glucan (patent application number:10-1805863), distilled water, glycerin, solubilizer, and 40% alcohol. We tested the efficacy and safety of the functional spray on six dogs with AD. The trial was conducted with the consent of the caregivers. The spray was applied to the skin lesions, including the trunk, axillae, inguinal region, or periocular areas, thrice a day for 30 days. To evaluate the efficacy of this functional spray, we assessed the pruritus visual analog scale (PVAS) and the canine atopic dermatitis extent and severity index (CADESI)-4. At the end of one month, the results clinical scores after functional spray treatment showed a significant decrease in the PVAS (p = 0.03) and CADESI-4 (p = 0.03) in all the subject dogs with AD. This study thus confirmed that the Synbio-glucan functional spray is efficacious and safe for the treatment of AD in dogs.

Keywords

Acknowledgement

This work was supported by Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ01395602), Rural Development Administration, Republic of Korea.

References

  1. Bashir KMI, Choi JS. Clinical and physiological perspectives of β-glucans: the past, present, and future. Int J Mol Sci 2017; 18: 1906.
  2. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Safety assessment of glycerin as used in cosmetics. Int J Toxicol 2019; 38(3 Suppl): 6S-22S. https://doi.org/10.1177/1091581819883820
  3. Boyle RJ, Tang ML. The role of probiotics in the management of allergic disease. Clin Exp Allergy 2006; 36: 568-576. https://doi.org/10.1111/j.1365-2222.2006.02472.x
  4. Brennan CS, Cleary LJ. The potential use of cereal (1→3,1→4)-β-d-glucans as functional food ingredients. J Cereal Sci 2005; 42: 1-13. https://doi.org/10.1016/j.jcs.2005.01.002
  5. Cafferata EA, Jerez A, Vernal R, Monasterio G, Pandis N, Faggion CM Jr. The therapeutic potential of regulatory T lymphocytes in periodontitis: a systematic review. J Periodontal Res 2019; 54: 207-217. https://doi.org/10.1111/jre.12629
  6. Cinque B, La Torre C, Melchiorre E, Marchesani G, Zoccali G, Palumbo P, et al. Use of probiotics for dermal applications. In: Liong MT, editor. Probiotics. Berlin: Springer. 2011: 221-241.
  7. Danby SG, Andrew PV, Taylor RN, Kay LJ, Chittock J, Pinnock A, et al. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis. Clin Exp Dermatol 2022; 47: 1154-1164. https://doi.org/10.1111/ced.15141
  8. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, et al. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Arch Surg 1999; 134: 977-983. https://doi.org/10.1001/archsurg.134.9.977
  9. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br J Dermatol 2005; 152: 202-216. https://doi.org/10.1111/j.1365-2133.2004.06436.x
  10. Gittler JK, Krueger JG, Guttman-Yassky E. Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol 2013; 131: 300-313. https://doi.org/10.1016/j.jaci.2012.06.048
  11. Goncalves BHR, Matos BD, Faleiro MBR, Arnhold E, Matos MPC, Santin API, et al. Correlation between clinical findings, mast cell count and interleukin 31 immunostaining in the skin of dogs with atopic dermatitis. Cienc Rural 2018; 48: e20180004.
  12. Greive K. Glycerine: the naturally effective humectant. Dermatol Nurs 2012; 11: 30-34.
  13. Gueniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V, et al. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp Dermatol 2010; 19: e1-e8. https://doi.org/10.1111/j.1600-0625.2009.00932.x
  14. Halliwell R. Revised nomenclature for veterinary allergy. Vet Immunol Immunopathol 2006; 114: 207-208. https://doi.org/10.1016/j.vetimm.2006.08.013
  15. Halvarsson K, Loden M. Increasing quality of life by improving the quality of skin in patients with atopic dermatitis. Int J Cosmet Sci 2007; 29: 69-83. https://doi.org/10.1111/j.1467-2494.2007.00364.x
  16. Han KJ, Lee JE, Lee NK, Paik HD. Antioxidant and anti-inflammatory effect of probiotic Lactobacillus plantarum KU15149 derived from Korean homemade diced-radish kimchi. J Microbiol Biotechnol 2020; 30: 591-598. https://doi.org/10.4014/jmb.2002.02052
  17. Hill PB, Lau P, Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Vet Dermatol 2007; 18: 301-308. https://doi.org/10.1111/j.1365-3164.2007.00616.x
  18. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Vet Immunol Immunopathol 2001; 81: 147-151. https://doi.org/10.1016/S0165-2427(01)00296-3
  19. Jesenak M, Banovcin P, Rennerova Z, Majtan J. β-Glucans in the treatment and prevention of allergic diseases. Allergol Immunopathol (Madr) 2014; 42: 149-156. https://doi.org/10.1016/j.aller.2012.08.008
  20. Jesenak M, Urbancek S, Majtan J, Banovcin P, Hercogova J. β-Glucan-based cream (containing pleuran isolated from pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis. J Dermatolog Treat 2016; 27: 351-354. https://doi.org/10.3109/09546634.2015.1117565
  21. Kim H, Kim HR, Kim NR, Jeong BJ, Lee JS, Jang S, et al. Oral administration of Lactobacillus plantarum lysates attenuates the development of atopic dermatitis lesions in mouse models. J Microbiol 2015; 53: 47-52. https://doi.org/10.1007/s12275-015-4483-z
  22. Kim IS, Lee SH, Kim JA, Yu DY, Hong YH, Kim JY, et al. Effect of oral administration of β-glucans derived from Aureobasidium pullulans SM-2001 in model mice and rat with atopic dermatitis-like phenotypes. Food Sci Biotechnol 2018; 27: 1185-1192. https://doi.org/10.1007/s10068-018-0322-4
  23. Kim IS, Lee SH, Kwon YM, Adhikari B, Kim JA, Yu DY, et al. Oral administration of β-glucan and Lactobacillus plantarum alleviates atopic dermatitis-like symptoms. J Microbiol Biotechnol 2019; 29: 1693-1706. https://doi.org/10.4014/jmb.1907.07011
  24. Kim JY, Choi EJ, Lee JH, Yoo MS, Heo K, Shim JJ, et al. Probiotic potential of a novel vitamin B2-overproducing Lactobacillus plantarum strain, HY7715, isolated from kimchi. Appl Sci 2021; 11: 1-18. https://doi.org/10.3390/app11135765
  25. Kim YH, Kang MS, Kim TH, Jeong Y, Ahn JO, Choi JH, et al. Anti-inflammatory and immune modulatory effects of synbio-glucan in an atopic dermatitis mouse model. Nutrients 2021; 13: 1090.
  26. Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics--a novel approach in the management of food allergy. Allergy 1999; 54: 909-915. https://doi.org/10.1034/j.1398-9995.1999.00103.x
  27. Kirmaz C, Bayrak P, Yilmaz O, Yuksel H. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study. Eur Cytokine Netw 2005; 16: 128-134.
  28. Kwon HK, Song MJ, Lee HJ, Park TS, Kim MI, Park HJ. Pediococcus pentosaceus-fermented Cordyceps militaris inhibits inflammatory reactions and alleviates contact dermatitis. Int J Mol Sci 2018; 19: 3504.
  29. Lakshmi AV. Riboflavin metabolism--relevance to human nutrition. Indian J Med Res 1998; 108: 182-190.
  30. Lasztity R. Oat grain-a wonderful reservoir of natural nutrients and biologically active substances. Food Rev Int 1998; 14: 99-119. https://doi.org/10.1080/87559129809541150
  31. Lee C, Verma R, Byun S, Jeun EJ, Kim GC, Lee S, et al. Structural specificities of cell surface β-glucan polysaccharides determine commensal yeast mediated immuno-modulatory activities. Nat Commun 2021; 12: 3611.
  32. Lee D, Kim Y, Jo H, Go C, Jeong Y, Jang Y, et al. The anti-inflammatory effect of aptamin C on house dust mite extract-induced inflammation in keratinocytes via regulation of IL-22 and GDNF production. Antioxidants (Basel) 2021; 10: 945.
  33. Lee JE, Lee NK, Paik HD. Antimicrobial and anti-biofilm effects of probiotic Lactobacillus plantarum KU200656 isolated from kimchi. Food Sci Biotechnol 2020; 30: 97-106. https://doi.org/10.1007/s10068-020-00837-0
  34. Lee KH, Park M, Ji KY, Lee HY, Jang JH, Yoon IJ, et al. Bacterial β-(1,3)-glucan prevents DSS-induced IBD by restoring the reduced population of regulatory T cells. Immunobiology 2014; 219: 802-812. https://doi.org/10.1016/j.imbio.2014.07.003
  35. Lee KI, Yun T, Ham J, Lee WK, Kang JH, Yang MP, et al. Clinical trial of oral administration of Bifidobacterium longum in dogs with atopic dermatitis. Korean J Vet Res 2020; 60: 19-24. https://doi.org/10.14405/kjvr.2020.60.1.19
  36. Loden M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997; 36: 256-260. https://doi.org/10.1111/j.1600-0536.1997.tb00213.x
  37. Marsella R, De Benedetto A. Atopic dermatitis in animals and people: an update and comparative review. Vet Sci 2017; 4: 37.
  38. Meydani SN, Ha WK. Immunologic effects of yogurt. Am J Clin Nutr 2000; 71: 861-872.
  39. Michail S. The role of probiotics in allergic diseases. Allergy Asthma Clin Immunol 2009; 5: 5.
  40. Michels GM, Walsh KF, Kryda KA, Mahabir SP, Walters RR, Hoevers JD, et al. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. Vet Dermatol 2016; 27: 505-e136.
  41. Miller WH Jr, Griffin CE, Campbell KL. Muller and Kirk's small animal dermatology. 7th ed. St. Louis (MO): Elsevier. 2012: 363-431.
  42. Olivry T, Foster AP, Mueller RS, McEwan NA, Chesney C, Williams HC. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 2010; 21: 4-22. https://doi.org/10.1111/j.1365-3164.2009.00784.x
  43. Olivry T, Saridomichelakis M, Nuttall T, Bensignor E, Griffin CE, Hill PB; International Committe on Allergic Diseases of Animals (ICADA). Validation of the canine atopic dermatitis extent and severity index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs. Vet Dermatol 2014; 25: 77-85, e25. https://doi.org/10.1111/vde.12107
  44. Petravic-Tominac V, Zechner-Krpan V, Grba S, Srecec S, Panjkota-Krbavcic I, Vidovic L. Biological effects of yeast β-glucans. Agric Conspec Sci 2010; 75: 149-158.
  45. Portera CA, Love EJ, Memore L, Zhang L, Muller A, Browder W, et al. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. Am Surg 1997; 63: 125-131.
  46. Ramio-Lluch L, Brazis P, Ferrer L, Puigdemont A. Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner compliance the main success-limiting factor? Vet Rec 2020; 187: 493.
  47. Roudsari MR, Karimi R, Sohrabvandi S, Mortazavian AM. Health effects of probiotics on the skin. Crit Rev Food Sci Nutr 2015; 55: 1219-1240. https://doi.org/10.1080/10408398.2012.680078
  48. Rybnicek J, Lau-Gillard PJ, Harvey R, Hill PB. Further validation of a pruritus severity scale for use in dogs. Vet Dermatol 2009; 20: 115-122. https://doi.org/10.1111/j.1365-3164.2008.00728.x
  49. Simpson E, Bohling A, Bielfeldt S, Bosc C, Kerrouche N. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat 2013; 24: 122-125. https://doi.org/10.3109/09546634.2012.713461
  50. Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin 2010; 26: 633-640. https://doi.org/10.1185/03007990903512156
  51. Sugiyama A, Hata S, Suzuki K, Yoshida E, Nakano R, Mitra S, et al. Oral administration of paramylon, a beta-1,3-D-glucan isolated from Euglena gracilis Z inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. J Vet Med Sci 2010; 72: 755-763. https://doi.org/10.1292/jvms.09-0526
  52. Takahashi H, Ohno N, Adachi Y, Yadomae T. Association of immunological disorders in lethal side effect of NSAIDs on beta-glucan-administered mice. FEMS Immunol Med Microbiol 2001; 31: 1-14.
  53. Vetvicka V, Vannucci L, Sima P, Richter J. Beta glucan: supplement or drug? From laboratory to clinical trials. Molecules 2019; 24: 1251.
  54. Watson TD. Diet and skin disease in dogs and cats. J Nutr 1998; 128(12 Suppl): 2783S-2789S. https://doi.org/10.1093/jn/128.12.2783S
  55. Wheatcroft R, Kulandai J, Gilbert RW, Sime KJ, Smith CG, Langeris WH, inventors; Carlton and United Breweries Ltd., assignee. Production of β-glucan-mannan preparations by autolysis of cells under certain pH, temperature and time conditions. United States patent US 6,444,448 B1. Sep 3, 2002.
  56. Wiles BM, Llewellyn-Zaidi AM, Evans KM, O'Neill DG, Lewis TW. Large-scale survey to estimate the prevalence of disorders for 192 Kennel Club registered breeds. Canine Genet Epidemiol 2017; 4: 8.
  57. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018; 32: 657-682. Erratum in: J Eur Acad Dermatol Venereol 2019; 33: 1436.
  58. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018; 32: 850-878. https://doi.org/10.1111/jdv.14888
  59. Xin Y, Ji H, Cho E, Roh KB, You J, Park D, et al. Immune-enhancing effect of water-soluble beta-glucan derived from enzymatic hydrolysis of yeast glucan. Biochem Biophys Rep 2022; 30: 101256.
  60. Yoshida Y, Seki T, Matsunaka H, Watanabe T, Shindo M, Yamada N, et al. Clinical effects of probiotic Bifidobacterium breve supplementation in adult patients with atopic dermatitis. Yonago Acta Med 2010; 53: 37-45.
  61. Yu J, Ma X, Wang X, Cui X, Ding K, Wang S, et al. Application and mechanism of probiotics in skin care: a review. J Cosmet Dermatol 2022; 21: 886-894. https://doi.org/10.1111/jocd.14734